Key result
[18F]AlF-NOTA-FAPI-04 PET/CT provided superior visualization of Kimura's disease lesions, demonstrating higher uptake and a clearer background compared to 18F-FDG PET/CT.
Why the study?
Does [18F]AlF-NOTA-FAPI-04 PET/CT improve imaging quality compared to 18F-FDG PET/CT in patients with Kimura's disease?
Case Report (n=1)
Does [18F]AlF-NOTA-FAPI-04 PET/CT improve imaging quality compared to 18F-FDG PET/CT in patients with Kimura's disease?
[18F]AlF-NOTA-FAPI-04 PET/CT provides superior imaging of fibroblast activation in Kimura's disease compared to 18F-FDG PET/CT, potentially improving diagnostic accuracy.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for FAPI PET in Kimura’s disease; prospective trials needed before any clinical adoption.
Kimura’s disease is a rare, chronic inflammatory disorder characterized by subcutaneous nodules, eosinophilia, and elevated serum IgE levels. It commonly affects young Asian males and typically presents in the head and neck region. Diagnosis is confirmed via histopathological examination, while treatment options include corticosteroids, surgery, and radiotherapy. [ 18 F]AlF-NOTA-FAPI-04 PET/CT demonstrated superior imaging, with clearer background and higher target-to-background ratio, highlighting lesions with higher SUV values and greater specificity for fibroblast activity. Compared to 18 F-FDG PET/CT, which is limited by nonspecific uptake in inflammatory tissues, [ 18 F]AlF-NOTA-FAPI-04 PET/CT offers superior sensitivity and specificity in visualizing fibroblast activation. These advantages not only improve diagnostic accuracy in Kimura’s disease but may also have broader implications for other eosinophilic or inflammatory disorders sharing similar clinical features. This technique improves diagnostic accuracy, facilitates treatment planning, and may guide the development of future treatment.
No takes yet. Share an insight, caveat, or question.
Sun et al. (2025) conducted a case report in Kimura's disease (n=1). [18F]AlF-NOTA-FAPI-04 PET/CT vs. 18F-FDG PET/CT was evaluated on SUVmax of right parotid gland nodule. [18F]AlF-NOTA-FAPI-04 PET/CT provided superior visualization of Kimura's disease lesions, demonstrating higher uptake and a clearer background compared to 18F-FDG PET/CT.
Synapse has enriched 10 related papers. Consider them for comparative context: